Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions

Enhanced Endothelial Tubule Formation in Response to Proly-Hydroxylase Inhibitor FG-2216: A Step Towards Therapeutic Angiogenesis in Chronic Total Occlusions

Bibliographic Details
Main Authors:	Barnett, G, Wrigley, B, Kelly, D, Flashman, E, Schofield, C, Gershlick, A
Format:	Conference item
Published:	2012

Similar Items

Pro-angiogenic effects of proly-hydroxylase inhibitor FG-2216 and potential for use in a novel strategy of therapeutic angiogenesis for difficult cases of coronary total occlusion
by: Barnett, G, et al.
Published: (2014)

74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.
by: Barnett, G, et al.
Published: (2014)

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.
by: Barnett, G, et al.
Published: (2013)

Evidence for a potential new method of therapeutic angiogenesis: Increased endothelial cell mobility and tubule formation in cell culture after stabilisation of hypoxia-inducible factor
by: Kelly, D, et al.
Published: (2008)

Increased endothelial cell mobility following stabilization of hypoxia-inducible factor-steps towards therapeutic angiogenesis
by: Kelly, D, et al.
Published: (2008)

In-vivo observations on angiogenesis: Dose-dependent effects of the prolyl-4-hydroxylase inhibitor, di-methyl oxalyl-glycine, on arterial development in embryonic zebrafish
by: Kelly, D, et al.
Published: (2008)

Therapeutic manipulation of the HIF hydroxylases.
by: Nagel, S, et al.
Published: (2010)

Therapeutic angiogenesis using genetically engineered human endothelial cells
by: Cho, Seung-Woo, et al.
Published: (2016)

In-vivo observations on angiogenesis in embryonic zebrafish: dose-dependent effects of the prolyl-4-hydroxylase inhibitor, Di-methyl oxalyl-glycine, on arterial development
by: Kelly, D, et al.
Published: (2008)

UPREGULATION OF HYPDXIA-INDUCIBLE FACTOR 1 alpha BY DI-METHYL OXALYL GLYCINE PROMOTES ANGIOGENESIS WITHIN ISCHAEMIC MYOCARDIUM IN A PORCINE CORONARY OCCLUSION MODEL
by: Kelly, D, et al.
Published: (2010)

Prolyl hydroxylases and therapeutics.
by: Smith, T, et al.
Published: (2010)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
by: Flashman, E, et al.
Published: (2010)

BIOL 56-ESI-MS studies on prolyl hydroxylase domain 2
by: Mecinovic, J, et al.
Published: (2008)

Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
by: Knowles, H, et al.
Published: (2004)

Use of mass spectrometry to probe the nucleophilicity of cysteinyl residues of prolyl hydroxylase domain 2.
by: Mecinović, J, et al.
Published: (2009)

The impact of proliferative potential of umbilical cord-derived endothelial progenitor cells and hypoxia on vascular tubule formation in vitro.
by: Zhang, Y, et al.
Published: (2009)

Anti-angiogenesis in cancer therapeutics: the magic bullet
by: Oguntade, AS, et al.
Published: (2021)

The molecular basis for ER tubule formation
by: Brady, J
Published: (2015)

Collagen Prolyl 4-Hydroxylase as a Therapeutic Target
by: Vasta, James D., et al.
Published: (2020)

Review of: Bailey, F.G. (ed.): Gifts and Poison
by: Ardener, E
Published: (1971)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
by: Flashman, E, et al.
Published: (2010)

Single cell decisions in endothelial population in the context of inflammatory angiogenesis
by: Rimchala, Tharathorn
Published: (2012)

Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.
by: da Silva, R, et al.
Published: (2010)

Role of angiogenesis in the pathogenesis of arthritis: Potential therapeutic applications
by: Kiriakidis, S, et al.
Published: (2011)

Studies on the brush border of the Kidney Proximal Tubule
by: Kramers, M
Published: (1974)

Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay.
by: Ehrismann, D, et al.
Published: (2007)

A novel approach to the synthesis of the FG fragment of pectenotoxin-4
by: Luscombe, KN
Published: (2012)

Oxygen sensing by HIF hydroxylases.
by: Schofield, C, et al.
Published: (2004)

Signalling hypoxia by HIF hydroxylases.
by: Schofield, C, et al.
Published: (2005)

A multiscale model of complex endothelial cell dynamics in early angiogenesis.
by: Stepanova, D, et al.
Published: (2021)

Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.
by: Li, J, et al.
Published: (2009)

Thymosin beta4 and angiogenesis: modes of action and therapeutic potential.
by: Smart, N, et al.
Published: (2007)

Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
by: Chowdhury, R, et al.
Published: (2009)

Biochemistry of the hypoxia-inducible factor hydroxylases
by: Fiorini, G, et al.
Published: (2024)

Dope-Dyeing of Polyvinyl Alcohol (PVA) Nanofibres with Remazol Yellow FG
by: Fadil, Fatirah, et al.
Published: (2020)

Natural frequency of F.G. rectangular plate by shear deformation theory
by: Shahrjerdi, Ali, et al.
Published: (2011)

Charge Influences Substrate Recognition and Self-Assembly of Hydrophobic FG Sequences
by: Chen, Wesley G, et al.
Published: (2021)

Natively Unfolded FG Repeats Stabilize the Structure of the Nuclear Pore Complex
by: Onischenko, Evgeny, et al.
Published: (2018)

Two differential binding mechanisms of FG-nucleoporins and nuclear transport receptors
by: Tan, P, et al.
Published: (2018)